Floatz logo

Therapeutic Asset Ratings

128 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Tislelizumab
Colon Cancer
fan liP3B (56)
Inno-206
Colon Cancer
City of Hope Medical CenterP2B (56)
Everolimus
Colon Cancer
Fudan UniversityP2CCC (55)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Colon Cancer
John Strickler, M.D.P2CCC (55)
Gastrografin
Colon Cancer
Region SkaneP3CCC (54)
MAGNESIUM METALLICUM
Colon Cancer
Region SkaneP3CCC (54)
Prucalopride
Colon Cancer
Region SkaneP3CCC (54)
SODIUM PHOSPHATE
Colon Cancer
Region SkaneP3CCC (54)
sodium picosulfate
Colon Cancer
Region SkaneP3CCC (54)
gsk1120212
Colon Cancer
City of Hope Medical CenterP2CCC (53)
Nuvastatic
Colon Cancer
Natureceuticals Sdn BhdP3CCC (52)
Xljdod Compound Granule
Colon Cancer
Jiangsu Famous Medical Technology Co., Ltd.P3CCC (52)
Adebrelimab
Colon Cancer
Korea University Anam HospitalP2CCC (52)
Entinostat
Colon Cancer
National Cancer Institute (NCI)P2CCC (52)
Fruquintinib
Colon Cancer
Korea University Anam HospitalP2CCC (52)
Regorafenib
Colon Cancer
City of Hope Medical CenterP2CCC (52)
Tas-102
Colon Cancer
Rutgers, The State University of New JerseyP2CCC (52)
Fludarabine
Colon Cancer
Essen BiotechP1/2CCC (52)
Ctx-009
Colon Cancer
Compass TherapeuticsP2CCC (51)
Rivoceranib
Colon Cancer
Fudan UniversityP2CCC (51)
Bms-907351
Colon Cancer
University of Colorado, DenverP2CCC (48)
Dostarlimab
Colon Cancer
Universitaire Ziekenhuizen KU LeuvenP2CCC (48)
Envafolimab
Colon Cancer
Sun Yat-sen UniversityP2CCC (48)
Ethiodized Oil
Colon Cancer
City of Hope Medical CenterP2CCC (48)
Fianlimab
Colon Cancer
John Strickler, M.D.P2CCC (48)
Showing 26 to 50 of 128 assets
PreviousPage 2 of 6Next